US · SNWV
SANUWAVE Health, Inc.
- Sector
- Healthcare · Medical - Devices
- Headquarters
- Suwanee, GA 30024
- Website
- sanuwave.com
Price · as of 2024-12-31
$15.73
Market cap 208.62M
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $536.70 | +3,311.95% |
| Intrinsic Value(DCF) | $680.08 | +4,223.46% |
| Graham-Dodd Method(GD) | — | — |
| Graham Formula(GF) | — | — |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2010 | $0.00 | $0.00 | |||
| 2011 | $0.00 | $0.00 | |||
| 2012 | $0.00 | $0.00 | |||
| 2013 | $0.00 | $0.00 | |||
| 2014 | $0.00 | $0.00 | |||
| 2015 | $0.00 | $0.00 | |||
| 2016 | $0.00 | $0.00 | |||
| 2017 | $0.00 | $542.25 | |||
| 2018 | $0.00 | $0.00 | |||
| 2019 | $0.00 | $661.48 | |||
| 2020 | $0.00 | $0.00 | |||
| 2021 | $0.00 | $0.00 | |||
| 2022 | $0.00 | $0.00 | |||
| 2023 | $0.00 | $0.00 | |||
| 2024 | $29.00 | $536.70 | $3,509.67 | $0.00 | $0.00 |
AI valuation
Our deep-learning model estimates SANUWAVE Health, Inc.'s (SNWV) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $536.70
- Current price
- $15.73
- AI upside
- +3,311.95%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$680.08
+4,223.46% upside
Graham-Dodd
—
— upside
Graham Formula
—
— upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| SNWV | SANUWAVE Health, Inc. | $15.73 | 208.62M | +3,312% | +4,223% | — | — | -4.13 | -10.18 | 3.97 | -8.74 | — | -5.46 | 75.23% | 16.60% | -96.13% | 112.25% | -90.44% | -119.43% | -2.00 | 0.40 | 0.43 | 0.32 | -0.92 | -4233.00% | 5999.00% | -14330.00% | 1.52% | 0.06 | -32.81% | 0.00% | 0.00% | 10.35% | 26.71 | 73.63 | 4.43 | -9.15 |
| FHTX | Foghorn Therapeutics Inc. | $5.68 | 332.74M | +360% | -68% | — | +572% | -2.86 | -5.45 | 10.98 | -0.43 | — | -5.45 | 100.00% | -454.31% | -383.24% | 141.17% | 39.62% | -30.40% | -0.82 | — | 3.73 | 3.64 | 0.19 | -3248.00% | -3383.00% | -1510.00% | -40.83% | -1.50 | 39.09% | 0.00% | 0.00% | 0.00% | -0.40 | -0.41 | 1.84 | -2.64 |
| HSDT | Solana Company | $1.87 | 75.36M | +7,559% | +13,131% | — | +2,272% | -77.89 | 863.60 | 1758.75 | -66.18 | — | 863.60 | -11.92% | -2673.65% | -2258.08% | -688.88% | 995.92% | -209.04% | 0.01 | -817.82 | 1.58 | 0.80 | 0.08 | -4052.00% | -1925.00% | 575.00% | -1.21% | -5.10 | 791.26% | 0.00% | 0.00% | 0.00% | -65.70 | -82.70 | 1756.68 | 140.75 |
| IMRX | Immuneering Corporation | $4.99 | 181.15M | — | — | — | — | -0.75 | 1.10 | — | -0.21 | -8.77 | 1.33 | 0.00% | — | — | -92.51% | -682.42% | -78.61% | 0.10 | — | 5.28 | 4.82 | 0.50 | 851.00% | — | 1171.00% | -120.87% | -7.33 | -586.70% | 0.00% | 0.00% | 0.00% | -0.21 | -0.25 | — | -6.82 |
| INGN | Inogen, Inc. | $6.10 | 165.61M | +2,817% | -47% | -59% | — | -7.38 | 0.87 | 0.48 | -24.21 | — | 1.11 | 47.58% | -8.66% | -6.52% | -12.43% | -34.66% | -7.65% | 0.09 | — | 3.12 | 2.49 | 31.71 | -4408.00% | 386.00% | 9321.00% | -12.86% | -0.18 | -25.47% | 0.00% | 0.00% | 0.00% | -2.18 | -3.05 | 0.19 | 1.50 |
| MASS | 908 Devices Inc. | $6.90 | 249.73M | +193% | -84% | — | — | -1.30 | 0.82 | 1.58 | -0.71 | -1.49 | 1.36 | 50.18% | -128.65% | -121.09% | -51.56% | -197.59% | -39.84% | 0.06 | — | 4.10 | 3.27 | 0.85 | 8761.00% | 1872.00% | 1382.00% | -32.80% | -1.20 | -79.76% | 0.00% | 0.00% | 0.00% | -0.40 | -1.01 | 0.52 | -1.50 |
| NNOX | Nano-X Imaging Ltd. | $2.37 | 151.12M | +990% | +2% | — | — | -6.62 | 1.87 | 31.38 | -6.41 | — | 2.97 | -94.03% | -502.93% | -474.31% | -27.83% | -46.04% | -24.97% | 0.04 | — | 5.63 | 5.37 | 0.71 | -1574.00% | 1391.00% | -1813.00% | -11.12% | -2.62 | -32.15% | 0.00% | 0.00% | 0.00% | -5.08 | -7.32 | 25.55 | 7.21 |
| OM | Outset Medical, Inc. | $3.49 | 63.91M | +1,299% | -32% | — | — | — | 0.43 | 0.45 | 0.16 | — | 0.43 | 39.13% | -55.84% | -68.34% | 0.00% | -100.69% | 0.00% | 0.82 | -4.78 | 6.67 | 5.24 | -1.11 | -8547.00% | 509.00% | -5980.00% | -86.78% | -1.23 | -71.12% | 0.00% | — | 15.34% | 0.15 | 0.21 | -0.08 | -5.38 |
| QTRX | Quanterix Corporation | $6.55 | 305.96M | +237% | -22% | -45% | — | -7.37 | 0.86 | 2.10 | -0.73 | -45.26 | 0.87 | 59.89% | -38.85% | -28.45% | -11.33% | -70.92% | -9.23% | 0.11 | — | 8.66 | 7.65 | 0.44 | 1628.00% | 1180.00% | 6982.00% | -13.57% | -0.84 | -51.94% | 0.00% | 0.00% | 0.00% | -0.61 | -0.83 | 0.24 | 1.46 |
| SENS | Senseonics Holdings, Inc. | $8.27 | 337.9M | +200% | +728% | — | — | -5.18 | -24.61 | 18.13 | -5.73 | -38.01 | -23.91 | 2.37% | -333.05% | -349.84% | -817.17% | 267.39% | -65.88% | -3.69 | -8.87 | 2.35 | 2.13 | 0.20 | 1364.00% | 37.00% | -1107.00% | -15.39% | -1.56 | 224.02% | 0.00% | 0.00% | 0.00% | -5.26 | -6.28 | 17.53 | -12.73 |
| SGHT | Sight Sciences, Inc. | $5.16 | 272.82M | +483% | -76% | — | — | -2.30 | 1.35 | 1.48 | -0.83 | — | 1.35 | 85.50% | -63.27% | -64.49% | -49.59% | -403.80% | -33.29% | 0.46 | -10.84 | 9.04 | 8.48 | 1.74 | -965.00% | -147.00% | -5261.00% | -19.22% | -1.44 | -181.68% | 0.00% | 0.00% | 0.00% | -0.76 | -1.69 | 0.48 | -1.67 |
About SANUWAVE Health, Inc.
SANUWAVE Health, Inc., a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company's lead regenerative product is the dermaPACE device for treating diabetic foot ulcers. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, which helps to restore the body's normal healing processes and regeneration. The company also focuses on applying its Pulsed Acoustic Cellular Expression technology in wound healing, orthopedic, plastic/cosmetic, and cardiac conditions. In addition, it offers UltraMIST, non-contact and non-thermal ultrasound therapy device used to treat diabetic foot ulcers, pressure ulcers, venous leg ulcers, deep tissue pressure injuries, and surgical wounds; and orthoPACE system to treat tendinopathies and acute and nonunion fractures. The company was founded in 2005 and is headquartered in Suwanee, Georgia.
- CEO
- Morgan C. Frank
- Employees
- 46
- Beta
- 1.29
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($680.08 ÷ $15.73) − 1 = +4,223.46% (DCF, example).